Category health

• Sun Pharma  

Managing Director: Dilip Shanghvi

Sun Pharmaceutical Industries Limited stands as India’s largest pharmaceutical company and ranks among the top six generic drug manufacturers globally. The company develops and markets a wide range of pharmaceutical formulations and active pharmaceutical ingredients (APIs), serving patients across more than 100 countries. In a recent strategic move, Sun Pharma completed the acquisition of 100 percent equity in Libra Merger Ltd, an Israel-based firm.

• Laborate 

Director – Arpit Bhatia, Laborate 

Laborate Pharmaceuticals India Ltd. is one of India’s leading pharmaceutical manufacturers, recognised for its high-quality formulations and growing global footprint. The company develops, manufactures, and markets a wide range of medicines across therapeutic segments including antibiotics, pain management, cardiovascular, and dermatology. With a presence in over 30 countries, Laborate delivers affordable and effective healthcare solutions to millions worldwide through its advanced manufacturing facilities and strong R&D capabilities.

• Cipla 

MD & Global CEO: Umang Vohra

Founded in 1935 by Khwaja Abdul Hamied, Cipla Limited is one of India’s most trusted and diversified pharmaceutical companies. Operating through two key segments Pharmaceuticals and New Ventures  the company focuses on developing and delivering high-quality, affordable medicines across therapeutic areas such as respiratory care, cardiovascular health, diabetes management, and mental well-being. With a strong global presence, Cipla continues to drive innovation and access to healthcare in over 80 countries worldwide.

• Mankind  Pharma  

CEO: Sheetal Arora

Incorporated in 1995, Mankind Pharma Limited is one of India’s leading pharmaceutical companies, known for its wide portfolio spanning antibiotics, gastrointestinal, cardiovascular, dermatological, and erectile dysfunction therapies. The company is committed to delivering affordable, high-quality healthcare solutions and improving patient outcomes across diverse medical needs. Demonstrating its focus on advanced research and innovation, Mankind Pharma made an additional investment of £1 million in Actimed Therapeutics in 2023 to support the development of novel treatments for cancer cachexia, amyotrophic lateral sclerosis (ALS), and other muscle-wasting disorders.

• Dr. Reddy’s Lab 

Co-chairman & MD: GV Prasad

Founded by Dr. Kallam Anji Reddy, Dr. Reddy’s Laboratories is a leading Indian multinational pharmaceutical company with a strong presence across global markets. Leveraging decades of research expertise and innovation, the company develops, manufactures, and markets a wide spectrum of high-quality medicines and active pharmaceutical ingredients (APIs) across major therapeutic areas. Strengthening its focus on women’s health and wellness, Dr. Reddy’s Laboratories recently acquired MenoLabs from Amyris Inc., expanding its portfolio in dietary supplements and holistic healthcare solutions.

• Aurobindo Pharma

Executive Chairman: P.V. Ramprasad Reddy

Founded in 1986 by Penaka Venkata Ramprasad Reddy and Kambam Nithyananda Reddy, Aurobindo Pharma Limited is one of India’s leading pharmaceutical companies, known for its strong presence in the production of generic medicines and active pharmaceutical ingredients (APIs). The company has built a robust global footprint through its commitment to quality, affordability, and innovation across multiple therapeutic segments. In a recent development, one of its subsidiaries received approval from the United States Food and Drug Administration (USFDA) for Posaconazole Injection, a key treatment used to prevent severe fungal infections.

• Lupin Limited 

Managing Director: Sharvil P. Patel

Lupin Limited is one of India’s leading pharmaceutical companies and ranks among the top global manufacturers of generic medicines. With a strong commitment to quality, innovation, and accessibility, the company operates across key therapeutic areas including paediatrics, cardiovascular health, anti-infectives, diabetology, respiratory care, and anti-tuberculosis treatments. Backed by world-class R&D and a growing international presence, Lupin continues to advance its mission of providing affordable healthcare solutions to patients in over 100 countries.

Manipal cGMP Forum & 3rd National cGMP Day Celebrate Excellence in Pharmaceutical Quality with Historic Postal Cover Release

Manipal, 11th October 2025: The Centre for cGMP at Manipal College of Pharmaceutical Sciences (MCOPS), a constituent Institution of Manipal Academy of Higher Education (MAHE), an Institution of Eminence Deemed to be University, hosted the inaugural Manipal cGMP Forum alongside the 3rd National cGMP Day celebration, marking a significant milestone in advancing pharmaceutical quality and manufacturing standards in India.

The event’s centrepiece was the release of India’s first Special Postal Cover dedicated to current Good Manufacturing Practices (cGMP)—a pioneering initiative conceived by Dr Girish Pai K, Coordinator, Centre for cGMP, MAHE, in collaboration with Sri. Bharat Shah, National President, IDMA, and Dr. George Patani, Senior Vice President, IDMA.

The Special Postal Cover was unveiled in the presence of eminent dignitaries, including Sri. Bharat Shah (National President, IDMA), Sri. K Raja Bhanu (Director General, Pharmexcil), Mrs. Aditi Kare Panandikar (Hon. General Secretary, IDMA), Sri. Amit Raj Sinha (MD & CEO, Sigachi Industries Ltd), Sri. K Prakash (Chief Postmaster General), Dr. Sharath Rao (Pro-Vice Chancellor, MAHE), and Dr. Srinivas Mutalik (Principal, MCOPS).

Lt. Gen. (Dr.) M. D. Venkatesh, VSM (Retd.), Vice Chancellor, MAHE, emphasized the significance: “This marks a momentous milestone as we celebrate 2025 as the ‘Year of Excellence in Industry-Academia Collaborations.’ The Special Postal Cover is expected to generate nationwide awareness on the importance of cGMP and medicine quality.”

Sri Bharat Shah, National President of IDMA, announced IDMA’s proud sponsorship of this maiden initiative, remarking, “We believe this is a pioneering initiative to raise awareness not only among industry professionals, academia and regulators, but also among dispensing pharmacists, the patient community and the general public.”

Dr. Girish Pai K presented the Centre’s inspiring journey since its 2023 inception, highlighting pioneering initiatives including the cGMP Awareness Series, cGMP Lecture Series, cGMP CONNECT Newsletter, and the Train the Pharmacists program. He described the Special Postal Cover as “a symbol of national recognition and respect for cGMP,” expressing gratitude to IDMA and Sri Bharat Shah for their generous sponsorship.

Dr. Pai also welcomed the inclusion of cGMP as an elective in the PCI-prescribed BPharm syllabus, calling it “a timely development, coinciding meaningfully with the third National cGMP Day celebrations.”

The forum featured several notable achievements and presentations. The prestigious National cGMP Day Award 2025 was conferred upon Mr. Ananthakrishna Padiyar, Chief of Quality, Cipla Ltd, Mumbai, in recognition of his exemplary contributions to pharmaceutical quality. Phase II of the MANIPAL cGMP MUSEUM was unveiled as a digital tribute to Dr. TMA Pai, generously sponsored by Sri. Mehul Shah, MD, Encube Ethicals Pvt Ltd. The latest edition of the cGMP CONNECT Newsletter, Vol 2, Issue 2, was also released during the event. Expert sessions were delivered by Mr. Dinesh Kashikar, Senior Consultant, Zenshin Pharmatek LLP, who elaborated on Revised Schedule M Guidelines, and Mr. Allen Dass, GM, Akums Drugs & Pharmaceuticals Ltd, who addressed Quality Issues and Business Impact. Best Poster Awards were presented to deserving participants with certificates, cash prizes, and Special cGMP Gifts sponsored by Akums Drugs & Pharmaceuticals Ltd.

Under the theme “cGMP for Sustainable Quality” (unveiled in April 2025), the conference featured plenary sessions, poster presentations, interactive industry-academia dialogues, and engaging student activities, including a Quality Jingle, Innovation Pitch, and Tree of Quality—fully sponsored by Akums.

Held at the Dr. TMA Pai Auditorium, Manipal, the forum successfully bridged the gap between revised Schedule M guidelines and academic understanding, bringing together industry leaders, academia, students, and regulatory experts.

The concept of National cGMP Day was initiated by Dr. Girish Pai K in 2023 and has been celebrated annually in collaboration with IDMA, PCI, FOPE, Pharmexcil, and other leading industry bodies.

The Centre for cGMP at MAHE expressed heartfelt gratitude to all participants, speakers, sponsors, and guests for making the Manipal cGMP Forum and National cGMP Day 2025.

Thiruvananthapuram, October 10, 2025: The Department of Maternal and Fetal Medicine and the Department of Obstetrics and Gynaecology at KIMSHEALTH, in association with the Royal College of Obstetricians and Gynaecologists (RCOG), will host FETOMAT 2025 – Current Updates in Feto-Maternal Medicine, a two-day international conference dedicated to the latest advancements in maternal and fetal health. The conference will be held on October 11 and 12, 2025, at O by Tamara, Thiruvananthapuram.

With the theme “Bridging Beginnings and Beyond”, the conference reflects a commitment to holistic care; from preconception planning and pregnancy management to postpartum wellbeing; ensuring comprehensive health for both mother and child. The scientific program, structured into three sessions each day, will feature 50 expert-led topics, addressing contemporary challenges and innovations in feto-maternal medicine. A distinguished panel of national and international faculty will contribute to enriching knowledge and fostering collaborative learning.

“KIMSHEALTH is proud to host this conference, uniting leading doctors from India and abroad to share insights and discuss the latest developments in perinatology and fetal medicine,” said Dr. M. I. Sahadulla, Chairman and Managing Director, KIMSHEALTH.

Dr. John Smoleniec, Conjoint Professor, Maternal Fetal Medicine, Liverpool Hospital,  New South Wales, Australia, and Dr. Suresh S, Director of Mediscan, Chennai, and a pioneer in fetal medicine in India, will be among the notable speakers sharing their clinical experiences with the delegates.

Key highlights include panel discussions on “Late Anomalies: Detection, Dilemma, and Decision-Making” and “Evaluation of the Small Fetus”, where experts will deliberate on the role of multidisciplinary care in managing high-risk pregnancies.

The conference will also mark the launch of Kerala’s first Perinatal Mental Health Clinic in the private sector, designed to support the emotional wellbeing of expectant mothers and emphasize that mental health is as vital as physical health.

“Kerala has successfully reduced infant mortality to 5 per 1,000 live births, which is  on par with developed countries. This achievement has been made possible by the State’s advanced perinatal care,” said Dr. Vidyalekshmy R, Senior Consultant, Department of High-Risk Pregnancy and Perinatology, and Organising Secretary of FETOMAT-2025.

Bengaluru, 9th October 2025: Aster Volunteers Mobile Medical Services (AVMMS), in association with Aster RV Hospital, successfully organized a Mega Blood Donation Camp for residents and employees at VBHC Palmhaven Apartments, Bangalore. The initiative witnessed the enthusiastic participation of 60 generous donors, each contributing towards saving lives and supporting the healthcare system’s ongoing need for blood.

The camp was part of Aster Volunteers’ continuous efforts to promote community health and encourage citizens to participate in life-saving causes. The medical team from Aster RV Hospital ensured that the entire process was conducted under strict medical supervision, maintaining the highest standards of hygiene and safety.

Speaking about the initiative, Mr. Parashuram, Deputy manager Aster RV, Aster Volunteer said, “Blood donation is one of the simplest yet most powerful acts of kindness. Every unit of blood can help save multiple lives, and we are grateful to all the volunteers who came forward today. Their compassion reinforces the spirit of community care that Aster strives to promote.”

This initiative reflects Aster’s ongoing mission to create healthier and more connected communities through accessible healthcare and volunteer-driven outreach programs. By joining hands with residential communities like VBHC Palmhaven, Aster Volunteers continues to spread awareness about the importance of regular blood donation and collective responsibility in healthcare.

La Densitae Academy introduces advanced fellowships in Trichology and Hair Transplantation with Langbustech University, USA

Pune, 6th October 2025 : La Densitae Academy of Hair and Skin Science, a leading name in hair restoration and trichology in India, has announced the launch of its advanced fellowship programs in collaboration with Langbustech University, New Jersey, USA.

These programs are designed to equip medical professionals with in-depth knowledge and hands-on training in trichology, hair transplantation, and restoration techniques. Aimed at bridging the gap between theory and clinical practice, the fellowships combine global academic standards with real-world application.

Program Highlights:

• Start Date: November 1, 2025

• Mode: On-campus (Pune) and Online

• Structure: Academic learning + practical training under expert mentorship

• Stipend/Scholarship: Up to 50% of course fees

Fellowship Options:

1. Advanced Fellowship in Trichology and Hair Transplantation

   • Eligibility: MBBS, Diploma Dermatology, MD Dermatology, MDS OMF

   • Duration: 1 Year

   • Fees: ₹12 lakhs

2. Fellowship in Clinical Trichology and Hair Transplantation

   • Eligibility: MBBS, Diploma Dermatology, MD Dermatology, MDS OMF

   • Duration: 6 Months

   • Fees: ₹6 lakhs

3. Fellowship in Trichology & Hair Restoration Procedure

   • Eligibility: MBBS, BDS, BAMS, BHMS

   • Duration: 6 Months

   • Fees: ₹6 lakhs

Expert Faculty:
The programs will be led by Dr. Gajanan Jadhao (MBBS, DDV), Founder and Director of La Densitae Hair Transplant Clinic, who brings over two decades of experience in hair restoration. The academic team also includes:

• Dr. Vikas Kamble (MBBS, MD Dermatology, DDV, Plastic Surgeon)

• Dr. Wasim Pathan (MDS OMF, Specialist Surgeon)

• Dr. Surabhi (MDS OMF, Specialist Surgeon)

Together, the faculty offers a diverse range of expertise across dermatology, plastic surgery, and surgical hair restoration.

“These programs are designed to bridge the gap between theory and practice in trichology and hair transplantation,” said Dr. Gajanan Jadhao. “With structured learning and global collaboration, we aim to equip the next generation of doctors with the skills, confidence, and exposure needed to thrive in this growing specialty.”

La Densitae Academy continues to pioneer innovation in hair science education. These new fellowships reflect its commitment to advancing medical training in India by integrating international standards with local expertise, opening new career pathways in hair and skin sciences.

Agartala, October 5, 2025: Odia Samaj Tripura, in collaboration with ILS Hospital, Agartala, organized a Free Health Check-up Camp at Durgabari Tea Estate on Sunday, October 5, 2025. The camp aimed to provide basic healthcare facilities and medical consultation to residents of Durgabari, Laxmilunga, and nearby areas.

A nine-member medical team from ILS Hospital, led by Dr. Tushar Tudu, rendered free health check-up and consultation services covering multiple disciplines such as orthopaedics, dermatology, paediatrics, and general medicine.

The camp commenced at 11:00 a.m., and around 80 beneficiaries, including children, youth, women, and elderly residents, registered for medical examination and advice.

Odia Samaj Tripura made all necessary arrangements for the smooth conduct of the camp, including seating facilities, waiting area, drinking water, distribution of medicines, and food packets for the registered beneficiaries and their attendants.

The event concluded at around 3:00 p.m., with villagers expressing heartfelt appreciation for the noble initiative and community service rendered by Odia Samaj Tripura in association with ILS Hospital, Agartala.

NEW DELHI, 04th October 2025: FICCI is organizing the 19th edition of its annual healthcare conference ‘FICCI HEAL 2025’, scheduled on 8-9 October 2025 at FICCI, New Delhi. The two-day event, supported by the Ministry of Health & Family Welfare (MoHFW) and NITI Aayog, will be addressed by Mr J P Nadda, Minister of Health & Family Welfare and Chemicals & Fertilizers, Government of India. Prof (Dr) V K Paul, Member (Health), NITI Aayog will share his vision on ‘Revolutionizing Care through AI’.

Mr Prataprao Jadhav, Minister of State for Health & Family Welfare and Ayush, Govt of India is slated to address as the Chief Guest for ‘FICCI Healthcare Excellence Awards 2025’ on 8th October along with Mr CK Mishra, Former Secretary to Government of India.

The theme of this year is ‘Care@25 – Defining Moments in Healthcare’, which commemorates 25 years of India’s healthcare transformation while envisioning the roadmap for the next 25. The two-day conference will serve as a platform to reflect on key policy milestones, institutional reforms, and innovations that have shaped the sector, while identifying pathways to build a healthcare system that is future-ready, inclusive, and globally benchmarked.

Dr Harsh Mahajan, Chair, FICCI Health Services Committee and Founder & Chairman, Mahajan Imaging & Labs, said, “In the past 25 years, India has moved from scarcity to scale in healthcare. Programs such as the National Health Mission, Ayushman Bharat, and the rollout of Health and Wellness Centres have expanded access like never before, while indigenous manufacturing and PLI initiatives have strengthened self-reliance. FICCI HEAL 2025 is an occasion to reflect on these defining moments and to deliberate on how we can build the next 25 years around innovation, equity, and global leadership.”

 Mr Varun Khanna, Chair of FICCI HEAL 2025; Co-Chair, FICCI Health Services Committee and Group Managing Director, Quality Care India Limited (Care, KIMS & Evercare), said, “India’s healthcare ecosystem stands at an inflection point. The future lies in accountable, patient-centric care powered by outcome-based frameworks that balance efficiency with quality. Robust digital systems and evidence-driven decisions will be key enablers. At HEAL 2025, discussions will focus on building a resilient, future-ready healthcare architecture aligned with the vision of a ‘Viksit Bharat’- delivering not just more care, but better care, accessible to all.”

Dr Anupam Sibal, Co-Chair, FICCI Health Services Committee and Group Medical Director, Apollo Hospitals Group, noted, “Over the past 25 years, India’s healthcare sector has witnessed remarkable expansion — reaching nearly US$ 372 billion in FY 2023 and projected to cross US$ 638 billion by 2025. The challenge now is to ensure this growth translates into greater efficiency and better outcomes. At HEAL 2025, the spotlight must be on how technology, AI, and digital innovation can drive smarter delivery models, while also expanding the workforce beyond the current 6 million to meet the demands of the future.”

The conference will start with the plenary – India’s Healthcare Odyssey: Legacy, Leadership & the Road to Viksit Bharat, bringing together industry Legends such as Dr Prathap C Reddy, Brig (Hony) Dr Arvind Lal, Dr Azad Moopen, Prof (Dr) SK Sarin, Dr M I Sahadulla, and Dr Narottam Puri. Sessions during the day will highlight reflections on the journey from the pioneers in Indian healthcare- the Torchbearers like Dr Sangita Reddy and Mr Dilip Jose, and the Visionaries of tomorrow like Mr Gautam Khanna and Dr Upasana Arora, who will share perspectives on growth, access, partnerships & equity, youth-led disruption, and deep tech innovations that will define healthcare in 2047. 

The event will also feature global experts- Mr Dan Vahdat, Founder and CEO, Huma Therapeutics and Ms Rajji Mehdwan, Managing Director & CEO- India & Neighbouring Markets, Roche Pharma, who will share their insights on Digital Health Learnings and Equitable Access to Medicines, respectively. Experts from BRICS nations will share their perspectives on Tackling NCDs in BRICS Economies through Equity and Innovation.

The FICCI HEAL Conference will have the following Thematic Sessions:

• True Accountable Care- Maximising Healthcare Delivery Impact, Efficiently
• From Silver to Strength: Charting India’s Path to Active and Healthy Ageing
• Transforming Primary Healthcare for Bharat through Bold Best and Collaborations
• Revolutionising Care through AI
• Therapeutics through Technology
• Hospital of the Future- Delivery Mechanisms for next 25 yrs

Key Speakers slated to address include:

• Dr (Prof) D S Rana, Chairman (Board of Trustees), Sir Ganga Ram Hospital
• Dr Raajiv Singhal, Co-Chair, FICCI Medical Value Travel Committee and Founding Member, Managing Director and Group CEO, Marengo Asia Hospitals
• Dr Dharminder Nagar, Managing Director, Paras Health
• Ms Alisha Moopen, Managing Director and Group CEO, Aster DM Healthcare, GCC; Deputy Managing Director, Aster DM Healthcare, India
• Ms Navika Kumar, Group Editor-in-Chief, Times Now & Times Now Navbharat
• Mr Shekhar Gupta, Editor-in-Chief and Chairman, ThePrint
• Dr Arun Agarwal, Chair- FICCI Task Force on Active & Healthy Ageing; Former Dean- MAMC, Former-Additional DGHS, GoI; Medical Advisor- Innovation, Education & Clinical Excellence, Apollo Hospitals Group
• Dr Y P Bhatia, Chairman & Managing Director, Astron Group
• Dr Shuchin Bajaj, Founder Director, Ujala Cygnus Healthcare Services
• Dr Sanjeev Singh, Medical Director, Amrita Institute of Medical Sciences & Research Centre (AIMSRC), Faridabad & Chief Medical Superintendent, AIMSRC Kochi
• Dr Girdhar Gyani, Director General, Association of Healthcare Providers (India)
• Mr Chakravarthy T Kannan, Secretary General, Quality Council of India (QCI)
• Dr Bishnu Panigrahi, Group Head – Medical Strategy and Operations, Fortis Healthcare
• Dr Uthappa P M, Group Medical Director, Narayana Health
• Mr Himanshu Baid, Managing Director, Poly Medicure (Polymed)
• Mr Atul Grover, Managing Director- India & South Asia, BD 
• Ms Malti Sachdev, Senior Vice President and Head Varian, India
• Mr Bharath Sesha, Managing Director, Philips India
• Dr Sudhir Srivastava, Founder, Chairman and CEO, SS Innovations
• Dr Sameer Gupta, Senior Interventional Cardiologist, MD – Aurum Senior & Assisted Living and Director- Metro Group of Hospitals
• Ms Harsimran Kaur, Vice President & Head of Strategy and Innovation, DC, Siemens Healthineers
• Mr Shankar Seshadri, Vice President- Indian Subcontinent, Elekta
• Mr Abhilash Sarangi, Director, Marketing, Intuitive India
• Ms Hema Jagota, Country Director, Clinical Solutions, Elsevier 
• Mr Vipul Jain, CEO, CK Birla Hospitals 
• Pawan Kumar, Director and CEO, Livasa Hospitals
• Dr Raajeev Virmani, Clinical Head- Ultrasound, Wipro GE HealthCare
• Mr Karthik Narayanaswamy, Partner and Head of India, Novo Holdings
• Mr Jagjit Singh, Chief Operating Officer, Care24
• Dr Ravi Gaur, Founder, DRG Path Labs and Chairman- Medical Advisory Committee, Oncquest Labs Ltd.
• Mr Kabir Mahajan, Chief Operating Officer, Mahajan Imaging & Labs
• Dr Suneela Garg, Professor Emeritus, National Academy of Medical Sciences (NAMS) and Former Head, Dept. of Community Medicine, MAMC
• Dr Monika Puri, Director- Market Access & Policy, Roche
• Mr Jaydeep Biswas, Chair-Policy, Advocacy & Partnerships, UNFPA India
• Dr Prasun Chatterjee, Chief-Geriatric Medicine & Longevity Science, Artemis Hospital and TAG Member for the Decade of Healthy Ageing, WHO

Mumbai, 4th October 2025:“Pharmacy isn’t just about what’s in your textbooks. It’s about applying knowledge, embracing innovation, and staying adaptable,” said Mr. Jeevan Kolhe, Senior Associate Scientist at Johnson & Johnson, while addressing aspiring pharmacists at NMIMS Mumbai.

Drawing from over a decade of experience in India’s pharmaceutical industry, Mr. Kolhe urged students to look beyond academics and gain real-world exposure. “The industry has evolved—from conventional drugs to biologics, cell and gene therapies, and COVID-19 vaccines developed with Indian collaboration. Understanding these shifts, especially the role of AI in quality control and manufacturing, is key to building a successful career.”

He outlined the diverse career opportunities in pharmacy today, including research and development, manufacturing, regulatory affairs, and data science. Sharing insights from his own journey, he said,     “I began my career in R&D before receiving my master’s results. Though I was offered a lower salary, I accepted the opportunity. Flexibility, a willingness to learn, and clear goals make a big difference early on.”

Highlighting the societal value of pharmacists, Mr. Kolhe noted, “It’s not just about working in labs. In some places, patients mix antibiotics with tap water instead of purified water, risking infections. Educating communities and leveraging technology like AI—used to detect tablet defects in size, shape, or color can greatly enhance safety and efficiency.”

The event was hosted by Reg Sphere, the student-led Regulatory Affairs Committee of NMIMS. Dr. Meena Chintamaneni, Pro-Vice Chancellor, emphasized the importance of the “Three Cs”: Connections, Confluence, and Compliance. “Compliance is fundamental, but you also need to build networks and combine academic knowledge with real-world trends. You can’t work in silos anymore.”

Dr. Jagannath Sahoo, Dean of the Shobhaben Pratapbhai Patel School of Pharmacy & Technology Management, encouraged students to contribute to India’s growing pharmaceutical prominence. He highlighted India’s edge as a global pharma hub—thanks to its skilled workforce, strategic positioning, cost advantages, and innovations like biosimilars that improve drug accessibility.

New Delhi, October, 03 2025: Alive Wellness Clinics, India’s leading destination for integrative skincare and wellness, founded by Dr. Chiranjiv Chhabra, hosted The Glow Affair, an evening dedicated to skincare, beauty, and holistic wellbeing at its flagship clinic in Lajpat Nagar. The event brought together friends of the brand, wellness seekers, and skincare enthusiasts for an afternoon of discovery, conversation, and indulgence.

The gathering was made even more special with the presence of Riddhima Kapoor Sahni, Face of the Brand, who was warmly greeted by guests and shared her personal take on beauty and wellness. Attendees also had the chance to meet and engage with her directly, making the evening interactive and memorable.

Guests further explored a curated showcase of Alive’s signature offerings, from focus medi-facials and personalised therapies to simplified skincare education. Guests were also introduced to some of the clinic’s most sought-after complementary services, including Exosomes, Skin Boosters, Lymphatic Drainage, I-Lipo, Diamond Oxy, Microneedling, and more, offering them a first-hand experience of the science and care behind modern skin health.

Speaking about the event, Dr. Chiranjiv Chhabra, Chief Dermatologist and Founder of Alive Wellness Clinics, said, “The Glow Affair is about bringing people closer to the possibilities of modern skincare while keeping it approachable and enjoyable. At Alive, we believe that real results come from a thoughtful blend of expertise, innovation, and everyday wellness practices, and that’s what we wanted our guests to experience firsthand.”

The evening went beyond treatments, creating an engaging environment. Guests enjoyed one-on-one consultations, quick luxe services, artisanal bites and sips, and exclusive event offers, making The Glow Affair a true celebration of wellness inside and out.

With this initiative, Alive Wellness Clinics reaffirmed its vision of creating spaces where expertise, self-care, and everyday confidence come together in a refreshing and meaningful way.

About Alive Wellness Clinics

Established in 1997 by Dr. Chiranjiv Chhabra, Alive Wellness Clinics has become a trusted name in transformative skin, body and hair and wellness care in India. Believing that beauty goes beyond the surface, the clinics combine advanced dermatology, clean science, and holistic healing into a cohesive experience. From personalised consultations to cutting-edge therapies, Alive Wellness Clinics continues to set benchmarks where modern expertise meets mindful living.

Bengaluru, September 29, 2025: In a vibrant show of community spirit and commitment to heart health, over 500 cyclists came together for a 10-km Cyclothon organized by Aster Whitefield Hospital in celebration of World Heart Day. The event served a dual purpose raising awareness about cardiovascular wellness and generating funds to support life-saving heart surgeries for underprivileged children.

Organized in partnership with Aster Volunteers, the CSR arm of Aster DM Healthcare, the initiative reinforced the hospital’s mission to blend clinical excellence with social responsibility.

Heart Failure Clinic Launched

Further underlining its commitment to advanced cardiac care, Aster Whitefield Hospital officially launched its new Heart Failure Clinic a state-of-the-art facility designed to offer comprehensive diagnosis, treatment, and long-term management for patients facing heart failure risks.

The clinic is led by two renowned cardiologists:

• Prof. Dr. Nagamalesh U M – Lead Consultant, Cardiology & Interventional Cardiology; Director  Heart Failure, Transplant & MCS Program

• Dr. Naveen Chandra G S – HOD & Lead Consultant, Interventional Cardiology

Leadership Speaks

“With this Cyclothon, we wanted to show that healthcare goes beyond hospital walls,” said Srikant Subudhi, Chief Operating Officer, Aster Whitefield Hospital. “It is about inspiring people to take charge of their heart health while also standing together for a larger cause. This event truly reflects our commitment to care, community, and compassion.”

The Power of Prevention

“Heart care doesn’t begin with surgery or medication — it begins with prevention,” said Prof. Dr. Nagamalesh U M. “Cycling symbolises endurance, discipline, and balance all essential for a healthy heart. Initiatives like this spread the message that prevention is just as vital as treatment.”

Collective Action for a Healthier Bengaluru

Echoing this sentiment, Dr. Naveen Chandra G S added, “The Cyclothon is proof of what collective action can achieve. By riding together, we are promoting fitness and giving hope to children with heart conditions. Small steps at an individual level can create powerful societal impact.”

With a powerful blend of fitness, awareness, and philanthropy, Aster Whitefield’s Cyclothon emerged as more than a sporting event it became a movement toward building a healthier, more compassionate Bengaluru.